Form 4 for ROIV Roivant Sciences Ltd.

Accepted 2025-04-23 00:00:00 ET · period of report 2025-04-21 · accession 0001140361-25-015254 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-04-23	2025-04-21	ROIV	Pulik Richard	CFO	A - Grant	$0.00	+141.5K	407.4K	+53%	$0
D	2025-04-23	2025-04-21	ROIV	Pulik Richard	CFO	A - Grant	$0.00	+180.4K	180.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares	2025-04-21	A	A	141,464	$0.00	407,352	D	—	—	(F1) Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2025. These RSUs service-vest as follows: (i) 25% on the date thirteen (13) months from the vesting commencement date; and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.
2	Derivative	Stock Option (Right to Buy)	2025-04-21	A	A	180,413	$0.00	180,413	D	$10.04 · — to 2035-04-20	180,413 Common Shares	(F2) Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2025. These options vest and become exercisable as follows: (i) 25% on the first anniversary of the vesting commencement date; and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.